Combined CD34 positive plus CD2 negative selection for effective T-cell depletion as GvHD-prophylaxis in HLA-nonidentical blood progenitor cell transplantation

Transfusion Science

Volumn 17, Issue 4, 1996, Pages 629-635

  Wiesneth, Markus ^a   Schreiner, Thomas ^a   Friedrich, Wilhelm ^b   Müller, Susanna ^b   Maccari, Birgit ^a   Erne, Elke ^a   Bischof, Christine ^a   Kubanek, Bernhard ^a  

^a German Red Cross Blood Bank   (Germany)

^b UNIVERSITY OF ULM   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CD2 ANTIGEN; CD34 ANTIGEN; LECTIN; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;

ACUTE LEUKEMIA; ADULT; ANTIGEN ANTIBODY REACTION; BONE MARROW; BONE MARROW TRANSPLANTATION; BONE PAIN; CELL SELECTION; CELL SEPARATION; CLINICAL ARTICLE; COMBINED IMMUNODEFICIENCY; CONFERENCE PAPER; DRUG MEGADOSE; FAMILY; FEMALE; GRAFT VERSUS HOST REACTION; HEADACHE; HLA MATCHING; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; IMMUNOADSORPTION; MALE; MYALGIA; NORMAL HUMAN; STEM CELL; SUBCUTANEOUS DRUG ADMINISTRATION; T LYMPHOCYTE;

EID: 0347874850     PISSN: 09553886     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0955-3886(96)90101-0     Document Type: Conference Paper

References (29)

1. Schmitz N, Dreger P, Suttorp M, et al: Primary transplantation of allogeneic peripheral blood progenitor cells mobilized by filgrastim (granulocyte colonystimulating factor). Blood 1995; 85:1666-1672.
2. Bensinger WJ, Weaver CH, Appelbaum FR, et al: Transplantation of allogeneic peripheral blood stem cells mobilized by recombinant human granulocyte colony-stimulating factor. Blood 1995; 85:1655-1658.
3. Arseniev L, Tischler HJ, Battmer K, Sudmeier I, Casper J, Link H: Treatment of poor marrow graft function with allogeneic CD34+ cells immunoselected from G-CSF mobilized peripheral blood progenitor cells of the marrow donor. Bone Marrow Transplant 1994; 14:791-797.
4. Dreger P, Haferlach T, Eckstein V, et al: G-CSF mobilized peripheral blood progenitor cells for allogeneic transplantation: safety, kinetics of mobilization, and composition of the graft. Br J Haematol 1994; 87:609-613.
5. Wiesneth M, Schreiner T, Frickhofen N, Friedrich W, Müller S, Kubanek B: Mobilization and collection of allogeneic and autologous peripheral blood progenitor cells for transplantation. Infusionsther Transfusionsmed 1995; 22 (Suppll 1):116-118.
6. Körbling M, Przepiorka D, Huh YO, et al.: Allogeneic blood stem cell transplantation for refractory leukemia, lymphoma: Potential advantage of blood over marrow allografts. Blood 1995; 85:1659-1665.
7. Rusell JA, Luider J, Weaver M, et al: Collection of progenitor cells for allogeneic transplantation from peripheral blood of normal donors. Bone Marrow Transplant 1995; 15:115.
8. Roberts MM, To LB, Gillis D, et al: Immune reconstitution following peripheral blood stem cell transplantation, autologous bone marrow transplantation and allogeneic bone marrow transplantation. Bone Marrow Transplant 1993; 12:469-475.
9. Wiesneth M: Rediscovery of T-cell depletion for allogeneic blood stem cell transplantation. Infusionsther Transfusionsmed 1995; 22 (Suppl 2):65.
10. Champlin R: Allogeneic peripheral blood progenitor cell transplantation: Considerations for stem cell selection and T-cell depletion. I. International Symposium on Allogeneic Peripheral Blood Progenitor Cell Transplantation, Geneva 1995; Abstract No. 14.
11. Schmitz N, Bacigalupo A, Labopin M, et al: Allogeneic peripheral blood progenitor cell transplantation (PBPCT) in Europe 1994. I. International Symposium on Allogeneic Peripheral Blood Progenitor Cell Transplantation, Geneva 1995; Abstract No. 20.
12. Przepiorka D, Anderlini P, Ippoliti C, et al: A comparison of outcomes by stem cell source and GvHD prophylaxis for allogeneic transplantation. I. International Symposium on Allogeneic Peripheral Blood Progenitor Cell Transplantation, Geneva 1995; Abstract No. 25.
13. Russell JA, Bowen T, Brown C, et al: Analysis of engraftment, acute and chronic GvHD in 32 patients of blood cell transplants from family donors. I. International Symposium on Allogeneic Peripheral Blood Progenitor Cell Transplantation, Geneva 1995; Abstract No. 27.
14. Wiesneth M, Hertenstein B, Bunjes D, et al.: T-cell depletion versus methotrexate as GvHD-prophylaxis in allogeneic bone marrow transplantation for leukaemia. Eur J Haematol 1988; 41:243-249.
15. Reisner Y, Kapoor N, Kirkpatrick D, Dupont B, Pollack MS, Good RA: Transplantation for acute leukaemia with HLA-A and B non-identical parental marrow fractionated with soybean agglutinin and sheep red blood cells. Lancet 1981; 2:327-331.
16. Prentice HG, Blacklock HA, Janossy G, et al: Depletion of T-lymphocytes in donor marrow prevents significant graftversus-host-disease in matched allogeneic leukaemia transplant recipients. Lancet 1984; 1:472-476.
17. Vartdal F, Kvalheim G, Lea T, et al: Depletion of T-lymphocytes from human bone marrow. Transplantation 1987; 43:366-371.
18. Dreger P, Viehmann K, Steinmann J, et al.: G-CSF mobilized peripheral blood progenitor cells for allogeneic transplantation: Comparison of T-cell depletion strategies using different CD34+ selection systems of Campath-1. Exp Hematol 1995; 23:147-154.
19. Raghavachar A, Frickhofen N, Arnold R, Schmeiser T, Prozsolt F, Heimpel H: Hematopoietic colony formation after allogeneic bone marrow transplantation: Enhancement by cyclosporin A and anti-gamma-(immune) interferon antiserum in-vitro. Exp Hematol 1986; 14:621-625.
20. Schreiner T, Wiesneth M, Slaper-Cortenbach I, et al: Improved lectin agglutination method for T-cell depletion of HLA-mismatched bone marrow grafts in children. Transfus Sci. 1996; 17:637-642.
21. Bunjes D, Hertenstein B, Wiesneth M, et al: In-vivo/ex-vivo T-cell depletion reduces the morbidity of allogeneic bone marrow transplantation in patients with acute leukaemias in first remission without increasing the risk of treatment failure: comparison with cyclosporin/ methotrexate. Bone Marrow Transplant 1995; 15:563-568.
22. Apperly JF, Mauro FR, Goldmann JM, et al: Bone marrow transplantation for chronic myeloid leukaemia in first chronic phase: importance of the graftversus-leukaemia effect. Br J Haematol 1988; 69:239-245.
23. Bunjes D, Heit W, Arnold R, et al: Evidence for the involvement of hostderived OKT8- positive T-cells in the rejection of T-depleted, HLA-identical bone marrow grafts. Transplantation 1987; 43:501-505.
24. Bordignon C, Keever CA, Small TN, et al: Graft failure after T-cell depleted human leukocyte antigen identical marrow transplants for leukaemia. II. In-vitro analysis of host effector mechanisms. Blood 1989; 74:2237-2243.
25. Kernan NA, Flomenberg N, Dupont B, O'Reilly RJ: Graft rejection in recipients of T-cell-depleted HLA-nonidentical marrow transplants for leukemia. Transplantation 1987; 43:842-847.
26. Hale G, Waldmann H: Control of graftversus-host disease and graft rejection by T-cell depletion of donor and recipient with Campath-1 antibodies. Results of matched sibling transplants for malignant disease. Bone Marrow Transplant 1994; 13:597-611.
27. Aversa F, Tabilio A, Terenzi A, Velardi A, et al: Successful engraftment of T-cell depleted haploidentical "three-loci" incompatible transplants in leukemia patients by addition of recombinant human granulocyte colony-stimulating factor-mobilized peripheral blood progenitor cells to bone marrow inoculum. Blood 1994; 84:3948-3955.
28. Friedrich W, Schreiner T, Müller S, Hartmann W, Wiesneth M, Kubanek B: Simultaneous grafting of T-cell depleted marrow and blood stem cells from HLA-nonidentical family donors. Bone Marrow Transplant 1995; 15 (Suppl 2):28.
29. Wiesneth M, Schreiner T, Friedrich W, Kubanek B: Mobilization of allogeneic blood stem cells and T-cell depletion of the graft. Bone Marrow Transplant 1995; 15 (Suppl 2):28.